New treatment guidelines for acute bipolar mania: A critical review

Journal of Affective Disorders

Volumn 140, Issue 2, 2012, Pages 125-141

  Nivoli, Alessandra M A ^a,b   Murru, Andrea ^a   Goikolea, José M ^a   Crespo, José M ^c   Montes, José M ^d   González Pinto, Ana ^d   García Portilla, Paz ^e   Bobes, Julio ^e   Sáiz Ruiz, Jerónimo ^f   Vieta, Eduard ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF SASSARI   (Italy)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^e UNIVERSITY OF OVIEDO   (Spain)

^f HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Bipolar mania; Guidelines; Treatment

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ASENAPINE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CLONAZEPAM; CLOZAPINE; ETIRACETAM; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; LITHIUM; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; PALIPERIDONE; PHENYTOIN; QUETIAPINE; RETIGABINE; RISPERIDONE; TAMOXIFEN; TOPIRAMATE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE; ZOTEPINE;

BIPOLAR MANIA; DISEASE SEVERITY; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; HUMAN; MONOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; HUMANS; PRACTICE GUIDELINES AS TOPIC; TRANQUILIZING AGENTS;

EID: 84862229244     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.10.015     Document Type: Review

References (93)

1. C.L. Bowden, A.M. Brugger, A.C. Swann, J.R. Calabrese, P.G. Janicak, F. Petty, S.C. Dilsaver, J.M. Davis, A.J. Rush, and J.G. Small Efficacy of divalproex vs. lithium and placebo in the treatment of mania. The Depakote Mania Study Group Journal of the American Medical Association 271 1994 918 924 (Pubitemid 24083217)
2. C.L. Bowden, H. Grunze, J. Mullen, M. Brecher, B. Paulsson, M. Jones, M. Vågerö, and K. Svensson A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder The Journal of Clinical Psychiatry 66 2005 111 121
3. C.L. Bowden, A.C. Swann, J.R. Calabrese, L.M. Rubenfaer, P.J. Wozniak, M.A. Collins, W. Abi-Saab, M. Saltarelli Depakote ER Mania Study Group A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania The Journal of Clinical Psychiatry 67 2006 1501 1510 (Pubitemid 44787431)
4. C. Bowden, A. Gogus, H. Grunze, L. Haggstrom, J. Rybakowski, and E. Vieta A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode International Clinical Psychopharmacology 23 2008 254 262
5. J.R. Calabrese, M. Cohen, J. Zhao, and J. Panagides Efficacy and safety of asenapine as adjunctive treatment for acute mania associated with bipolar disorder Proceedings of the 161th APA Conference, Washington, DC, May 3-8 2008
6. A. Cipriani, C. Barbui, G. Salanti, J. Rendell, R. Brown, S. Stockton, M. Purgato, L.M. Spineli, G.M. Goodwin, and J.R. Geddes Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis Lancet 378 9799 2011 1306 1315
7. A.J. Cutler, C. Datto, A. Nordenhem, B. Dettore, L. Acevedo, and D. Darko Effectiveness of extended release formulation of quetiapine as montherapy for the treatment of acute bipolar mania (trial D144CC00004) The International Journal of Neuropsychopharmacology 11 2008 184
8. E.B. Dennehy, T. Suppes, A.J. Rush, A.L. Miller, M.H. Trivedi, M.L. Crismon, T.J. Carmody, and T.M. Kashner Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project Psychological Medicine 35 2005 1695 1706 (Pubitemid 41672348)
9. R.S. El Mallakh, E. Vieta, L. Rollin, R. Marcus, W.H. Carson, and R. McQuade A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007) European Neuropsychopharmacology 20 2010 776 783
10. K.N. Fountoulakis, E. Vieta, J. Sanchez-Moreno, S.G. Kaprinis, J.M. Goikolea, and G.S. Kaprinis Treatment guidelines for bipolar disorder: a critical review Journal of Affective Disorders 86 2005 1 10 (Pubitemid 40487954)
11. T.W. Freeman, J.L. Clothier, P. Pazzaglia, M.D. Lesem, and A.C. Swann A double-blind comparison of valproate and lithium in the treatment of acute mania The American Journal of Psychiatry 149 1992 108 111
12. S.N. Ghaemi The newest mania: seeing disease mongering everywhere PLoS Medicine 3 2006 e319
13. S.N. Ghaemi From BALANCE to DSM-5: taking lithium seriously Bipolar Disorders 12 2010 673 677
14. S.N. Ghaemi, M. Bauer, F. Cassidy, G.S. Malhi, P. Mitchell, J. Phelps, E. Vieta, E. Youngstrom ISBD Diagnostic Guidelines Task Force Diagnostic guidelines for bipolar disorder: a summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force Report Bipolar Disorders 10 2008 117 128
15. A. González-Pinto, S. Barbeito, M. Alonso, S. Alberich, M.K. Haidar, E. Vieta, R. Tabarés-Seisdedos, I. Zorrilla, M.A. González-Pinto, and P. López Poor long-term prognosis in mixed bipolar patients: 10-year outcomes in the vitoria prospective naturalistic study in Spain The Journal of Clinical Psychiatry 72 2011 671 676
16. G.M. Goodwin Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder The British Journal of Psychiatry 164 1994 149 152
17. G.M. Goodwin, and Consensus Group of the British Association for Psychopharmacology Evidence-based guidelines for treating bipolar disorder: revised second edition - recommendations from the British Association for Psychopharmacology Journal of Psychopharmacology 23 2009 346 388
18. G. Goodwin, W. Fleischhacker, C. Arango, P. Baumann, M. Davidson, M. de Hert, P. Falkai, S. Kapur, S. Leucht, R. Licht, D. Naber, V. O'Keane, G. Papakostas, E. Vieta, and J. Zohar Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice European Neuropsychopharmacology 19 2009 520 532
19. H. Grunze, S. Kasper, G. Goodwin, C. Bowden, D. Baldwin, R.W. Licht, E. Vieta, H.J. Möller WFSBP Task Force on Treatment Guidelines for Bipolar Disorders The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part II: treatment of mania The World Journal of Biological Psychiatry 4 2003 5 13
20. H. Grunze, E. Vieta, G.M. Goodwin, C. Bowden, R.W. Licht, H.J. Moller, and S. Kasper The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania World Journal of Biological Psychiatry 10 2009 85 116
21. H. Grunze, E. Vieta, G. Goodwin, C. Bowden, R.W. Licht, H.J. Moller, S. Kasper WFSBP Task Force On Treatment Guidelines For Bipolar Disorders The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of bipolar depression The World Journal of Biological Psychiatry 11 2010 81 109
22. J.M. Haro, C. Reed, A. Gonzalez-Pinto, D. Novick, J. Bertsch, E. Vieta for the EMBLEM Advisory Board 2-year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery European Neuropsychopharmacology 21 2010 287 293
23. R.M. Hirschfeld, P.E. Keck Jr., M. Kramer, K. Karcher, C. Canuso, M. Eerdekens, and F. Grossman Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial Am. J. Psychiatry. 161 6 2004 1057 1065 (Pubitemid 38735992)
24. R.M. Hirschfeld, J.B. Williams, R.L. Spitzer, J.R. Calabrese, L. Flynn, P.E. Keck Jr., L. Lewis, S.L. McElroy, R.M. Post, D.J. Rapport, J.M. Russell, G.S. Sachs, and J. Zajecka Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire The American Journal of Psychiatry 157 2000 1873 1875
25. P.E. Keck, R. Marcus, S. Tourkodimitris, M. Ali, A. Liebeskind, A. Saha, and G. Ingenito A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania The American Journal of Psychiatry 160 2003 1651 1658 (Pubitemid 41079552)
26. P.E. Keck, M. Versiani, S. Potkin, S.A. West, E. Giller, and K. Ice Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial The American Journal of Psychiatry 160 2003 741 748 (Pubitemid 41079608)
27. P.E. Keck Jr., J.R. Calabrese, R.D. McQuade, W.H. Carson, B.X. Carlson, L.M. Rollin, R.N. Marcus, R. Sanchez Aripiprazole Study Group A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder The Journal of Clinical Psychiatry 67 2006 626 637 (Pubitemid 43764240)
28. P.E. Keck, P.J. Orsulak, A.J. Cutler, R. Sanchez, A. Torbeyns, R.N. Marcus, R.D. McQuade, W.H. Carson CN138-135 Study Group Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study Journal of Affective Disorders 112 2009 36 49
29. S. Khanna, E. Vieta, B. Lyons, F. Grossman, M. Eerdekens, and M. Kramer Risperidone in the treatment of acute mania: double-blind, placebo-controlled study The British Journal of Psychiatry 187 2005 229 234 (Pubitemid 41306103)
30. S.F. Kushner, A. Khan, R. Lane, and W.H. Olson Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials Bipolar Disorders 8 2006 15 27 (Pubitemid 43356017)
31. R.W. Licht Limitations in randomised controlled trials evaluating drug effects in mania European Archives of Psychiatry and Clinical Neuroscience 251 2001 66 71 (Pubitemid 34020521)
32. G.S. Malhi, D. Adams, L. Lampe, M. Paton, N. O'Connor, L.A. Newton, G. Walter, A. Taylor, R. Porter, R.T. Mulder, and M. Berk Clinical practice recommendations for bipolar disorder Acta Psychiatrica Scandinavica 439 2009 27 46
33. A. Martinez-Arán, E. Vieta, K.N. Chengappa, S. Gershon, J. Mullen, and B. Paulsson Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change Bipolar Disorders 10 2008 566 579 (Pubitemid 352003825)
34. S.L. McElroy, P.E. Keck, S.P. Stanton, K.C. Tugrul, J.A. Bennett, and S.M. Strakowski A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania The Journal of Clinical Psychiatry 57 1996 142 146 (Pubitemid 26123359)
35. R.S. McIntyre, M. Brecher, B. Paulsson, K. Huizar, and J. Mullen Quetiapine or haloperidol as monotherapy for bipolar mania: a 12-week, double-blind, randomised, parallel-group, placebocontrolled trial European Neuropsychopharmacology 15 2005 573 585 (Pubitemid 41219629)
36. R.S. McIntyre, M. Cohen, J. Zhao, L. Alphs, T.A. Macek, and J. Panagides Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial Journal of Affective Disorders 122 2010 27 38
37. K. Meenhan, F. Zhang, S. David, M. Tohen, P. Janicak, J. Small, M. Koch, R. Rizk, D. Walker, P. Tran, and A. Breier A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania Journal of Clinical Psychopharmacology 21 2001 389 397 (Pubitemid 32673028)
38. K.R. Merikangas, H.S. Akiskal, J. Angst, P.E. Greenberg, R.M. Hirschfeld, M. Petukhova, and R.C. Kessler Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication Archives of General Psychiatry 64 2007 543 552 (Pubitemid 46718287)
39. A. Murru, F. Colom, A.M. Nivoli, I. Pacchiarotti, M. Valenti, and E. Vieta When should mood stabilizers be withdrawn due to lack of efficacy? Some methodological considerations European Psychiatry 26 2011 183 186
40. National Institute for Health and Clinical Excellence (NICE) Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care NICE Clinical Guideline 38 2006
41. National Institute for Health and Clinical Excellence (NICE) Update 2009. Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care NICE Clinical Guideline 38 2009
42. G. Niufan, M. Tohen, A. Qiuqing, Y. Fude, E. Pope, H. McElroy, L. Ming, W. Gaohua, Z. Xinbao, L. Huichun, and S. Liang Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial Journal of Affective Disorders 105 2008 101 108 (Pubitemid 350245681)
43. A.M. Nivoli, F. Colom, A. Murru, I. Pacchiarotti, P. Castro-Loli, A. González-Pinto, K.N. Fountoulakis, and E. Vieta New treatment guidelines for acute bipolar depression: a systematic review Journal of Affective Disorders 126 2010 55 60
44. R.H. Perlis Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians Current Medical Research and Opinion 23 2007 467 475 (Pubitemid 46456895)
45. R.H. Perlis, R.W. Baker, C.A. Zarate Jr., E.B. Brown, L.M. Schuh, H.H. Jamal, and M. Tohen Olanzapine versus risperidone in the treatment of manic or mixed states in bipolar I disorder: a randomized, double-blind trial The Journal of Clinical Psychiatry 67 2006 1747 1753 (Pubitemid 44955156)
46. R.H. Perlis, J.A. Welge, L.A. Vornik, R.M. Hirschfeld, and P.E. Keck Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials The Journal of Clinical Psychiatry 67 2006 509 516 (Pubitemid 43764227)
47. H.G. Pope, S.L. McElroy, P.E. Keck, and J.I. Hudson Valproate in the treatment of acute mania. A placebo-controlled study Archives of General Psychiatry 48 1991 62 68
48. S.G. Potkin, P.E. Keck Jr., S. Segal, K. Ice, and P. English Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial Journal of Clinical Psychopharmacology 25 2005 301 310 (Pubitemid 41065070)
49. C. Reed, D. Novick, A. Gonzalez-Pinto, J. Bertsch, and J.M. Haro Observational study designs for bipolar disorder - what can they tell us about treatment in acute mania? Progress in Neuro-Psychopharmacology & Biological Psychiatry 15 2009 715 721
50. J.M. Rendell, H.J. Gijsman, M.S. Bauer, G.M. Goodwin, and G.R. Geddes Risperidone alone or in combination for acute mania Cochrane Database of Systematic Reviews 25 2006 CD004043
51. A.R. Rosa, M. Reinares, C. Franco, M. Comes, C. Torrent, J. Sánchez-Moreno, A. Martínez-Arán, M. Salamero, F. Kapczinski, and E. Vieta Clinical predictors of functional outcome of bipolar patients in remission Bipolar Disorders 11 2009 401 409
52. A.R. Rosa, N. Cruz, C. Franco, J.M. Haro, J. Bertsch, C. Reed, T.F. Aarre, J. Sanchez-Moreno, and E. Vieta Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study The Journal of Clinical Psychiatry 71 2010 1000 1006
53. G.S. Sachs, F. Grossman, S.N. Ghaemi, A. Okamoto, and C.L. Bowden Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety The American Journal of Psychiatry 159 2002 1146 1154 (Pubitemid 34743254)
54. G. Sachs, K.N. Chengappa, T. Suppes, J.A. Mullen, M. Brecher, and N.A. Devine Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, doubleblind, placebo-controlled study Bipolar Disorders 6 2004 213 223 (Pubitemid 38702297)
55. Sachs G., R. Sanchez, R. Marcus, E. Stock, R. McQuade, W. Carson, N. Abou-Gharbia, C. Impellizzeri, S. Kaplita, L. Rollin, T. Iwamoto Aripiprazole Study Group Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study Journal of Psychopharmacology 20 2006 536 546 (Pubitemid 43875183)
56. J. Sanchez-Moreno, A. Martinez-Aran, R. Tabarés-Seisdedos, C. Torrent, E. Vieta, and J.L. Ayuso-Mateos Functioning and disability in bipolar disorder: an extensive review Psychotherapy and Psychosomatics 78 2009 285 297
57. J. Segal, M. Berk, and S. Brook Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial Clinical Neuropharmacology 21 1998 176 180 (Pubitemid 28248777)
58. P.G. Shekelle, S.H. Woolf, M. Eccles, and J. Grimshaw Clinical guidelines: developing guidelines BMJ 318 1996 593 596
59. P. Sierra, L. Livianos, and L. Rojo Quality of life for patients with bipolar disorder: relationship with clinical and demographic variables Bipolar Disorders 7 2005 159 165 (Pubitemid 40439476)
60. J.G. Small, M.H. Klapper, J.D. Marhenke, V. Milstein, G.C. Woodham, and J.J. Kellams Lithium combined with carbamazepine or haloperidol in the treatment of mania Psychopharmacology Bulletin 31 1995 265 272
61. L.A. Smith, V. Cornelius, A. Warnock, M.J. Tacchi, and D. Taylor Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials Bipolar Disorders 9 2007 551 560 (Pubitemid 47365622)
62. A.B. Smulevich, S. Khanna, M. Eerdekens, K. Karcher, M. Kramer, and F. Grossman Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol European Neuropsychopharmacology 15 2005 75 84 (Pubitemid 39574402)
63. M. Tohen, T.M. Sanger, S.L. McElroy, G.D. Tollefson, K.N. Chengappa, D.G. Daniel, F. Petty, F. Centorrino, R. Wang, S.L. Grundy, M.G. Greaney, T.G. Jacobs, S.R. David, and V. Toma Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group The American Journal of Psychiatry 156 1999 702 709 (Pubitemid 29220067)
64. M. Tohen, T.G. Jacobs, S.L. Grundy, S.L. McElroy, M.C. Banov, and P.G. Janicak Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group Archives of General Psychiatry 57 2000 841 849
65. M. Tohen, K.N. Chengappa, T. Suppes, C.A. Zarate, J.R. Calabrese, and C.L. Bowden Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy Archives of General Psychiatry 59 2002 62 69 (Pubitemid 34044408)
66. M. Tohen, J.F. Goldberg, A.M. Gonzalez-Pinto Arrillaga, J.M. Azorin, E. Vieta, M.C. Hardy-Bayle, W.B. Lawson, R.A. Emsley, F. Zhang, R.W. Baker, R.C. Risser, M.A. Namjoshi, A.R. Evans, and A. Breier A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania Archives of General Psychiatry 60 2003 1218 1226 (Pubitemid 37494075)
67. M. Tohen, T.A. Ketter, C.A. Zarate, T. Suppes, M. Frye, L. Altshuler, J. Zajecka, L.M. Schuh, R.C. Risser, E. Brown, and R.W. Baker Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study American Journal of Psychiatry 160 2003 1263 1271 (Pubitemid 41070942)
68. M. Tohen, J.R. Calabrese, G.S. Sachs, M.D. Banov, H.C. Detke, R. Risser, R.W. Baker, J.C. Chou, and C.L. Bowden Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine American Journal of Psychiatry 163 2006 247 256 (Pubitemid 44480844)
69. M. Tohen, C.L. Bowden, A.B. Smulevich, R. Bergstrom, T. Quinlan, and O. Osuntokun Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes The British Journal of Psychiatry 192 2008 135 143 (Pubitemid 351269648)
70. M. Tohen, E. Vieta, G.M. Goodwin, B. Sun, J.D. Amsterdam, M. Banov, A. Shekhar, S.T. Aaronson, L. Bardenstein, I. Grecu-Gabos, V. Tochilov, D. Prelipceanu, H.S. Oliff, L. Kryzhanovskaya, and C. Bowden Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study The Journal of Clinical Psychiatry 69 2009 1776 1789
71. M. Tohen, E. Frank, C.L. Bowden, F. Colom, S.N. Ghaemi, L.N. Yatham, G.S. Malhi, J.R. Calabrese, W.A. Nolen, E. Vieta, F. Kapczinski, G.M. Goodwin, T. Suppes, G.S. Sachs, K.R. Chengappa, H. Grunze, P.B. Mitchell, S. Kanba, M. Berk The International Society for Bipolar Disorders (ISBD) Task force report on the nomenclature of course and outcome in bipolar disorders Bipolar Disorders 11 2009 453 473
72. E. Vieta New guidelines for bipolar disorders The World Journal of Biological Psychiatry 10 2009 82 84
73. E. Vieta Divalproeax versus olanzapine in mania The Journal of Clinical Psychiatry 64 2009 1266
74. E. Vieta, and C. Morralla Prevalence of mixed mania using 3 definitions Journal of Affective Disorders 125 2010 61 73
75. E. Vieta, J.R. Calabrese, J. Hennen, F. Colom, A. Martínez- Arán, J. Sánchez-Moreno, L.N. Yatham, M. Tohen, and R.J. Baldessarini Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data The Journal of Clinical Psychiatry 65 2004 1420 1428
76. E. Vieta, W.A. Nolen, H. Grunze, R.W. Licht, and G. Goodwin A European perspective on the Canadian guidelines for bipolar disorder Bipolar Disorders 7 2005 73 76 (Pubitemid 41065250)
77. E. Vieta, F. Panicali, I. Goetz, C. Reed, M. Comes, and M. Tohen Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study Journal of Affective Disorders 106 2008 63 72
78. E. Vieta, C. T'joen, R.D. McQuade, W.H. Carson Jr., R.N. Marcus, R. Sanchez, R. Owen, and L. Nameche Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study The American Journal of Psychiatry 165 2008 1316 1325
79. E. Vieta, J. Berwaerts, I. Nuamah, P. Lim, E. Yuen, and J. Palumbo Randomised, placebo, active-controlled study of paliperidone extended-release (ER) for acute manic and mixed episodes in bipolar I disorder European Neuropsychopharmacology Bipolar Disorders 12 2010 230 243
80. E. Vieta, T.S. Ramey, D. Keller, P.A. English, A.D. Loebel, and J.J. Miceli Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study Journal of Psychopharmacology 24 2010 547 558
81. R.H. Weisler, A.H. Kalali, and T.A. Ketter A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes The Journal of Clinical Psychiatry 65 2004 478 484
82. R. Weisler, L. Warrington, and J. Dunn Adjunctive ziprasidone in bipolar mania: short- and long-term data Biological Psychiatry 55 2004 148
83. R.H. Weisler, P.E. Keck Jr., A.C. Swann, A.J. Cutler, T.A. Ketter, and A.H. Kalali Extended-release carbamazepine capsules as the WFSBP guidelines for the biological treatment of bipolar disorders 31 monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial The Journal of Clinical Psychiatry 66 2005 323 330 (Pubitemid 40476755)
84. M. Wolfsperger, W. Greil, W. Rössler, and R. Grohmann Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004 Journal of Affective Disorders 99 2007 9 17 (Pubitemid 46275019)
85. L.N. Yatham, F. Grossman, I. Augustyns, E. Vieta, and A. Ravindran Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial The British Journal of Psychiatry 182 2003 141 147 (Pubitemid 36177237)
86. L.N. Yatham, S.H. Kennedy, C. O'Donovan, S. Parikh, G. MacQueen, R. McIntyre, V. Sharma, P. Silverstone, M. Alda, P. Baruch, S. Beaulieu, A. Daigneault, R. Milev, L.T. Young, A. Ravindran, A. Schaffer, M. Connolly, C.P. Gorman Canadian Network for Mood and Anxiety Treatments Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies Bipolar Disorders 7 2005 5 69 (Pubitemid 41065248)
87. L.N. Yatham, S.H. Kennedy, C. O'Donovan, S.V. Parikh, G. MacQueen, R.S. McIntyre, V. Sharma, S. Beaulieu Guidelines Group CANMAT Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007 Bipolar Disorders 8 2006 721 739 (Pubitemid 44824712)
88. L.N. Yatham, E. Vieta, A.H. Young, H.J. Moller, B. Paulsson, and M. Vagero A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania International Clinical Psychopharmacology 22 2007 212 220 (Pubitemid 46801944)
89. L.N. Yatham, S.H. Kennedy, A. Schaffer, S.V. Parikh, S. Beaulieu, C. O'Donovan, G. MacQueen, R.S. McIntyre, V. Sharma, A. Ravindran, L.T. Young, A.H. Young, M. Alda, R. Milev, E. Vieta, J.R. Calabrese, M. Berk, K. Ha, and F. Kapczinski Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009 Bipolar Disorders 11 2009 225 255
90. A. Yildiz, E. Vieta, S. Leucht, and R.J. Baldessarini Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials Neuropsychopharmacology 36 2011 375 389
91. A.H. Young, D.A. Oren, A. Lowy, R.D. McQuade, R.N. Marcus, and W.H. Carson Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study The British Journal of Psychiatry 194 2009 40 48
92. J.M. Zajecka, R. Weisler, G. Sachs, A.C. Swann, P. Wozniak, and K.W. Sommerville A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder The Journal of Clinical Psychiatry 63 2002 1148 1155 (Pubitemid 36084060)
93. D.L. Zimbroff, R.N. Marcus, G. Manos, E. Stock, R.D. McQuade, P. Auby, and D.A. Oren Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole Journal of Clinical Psychopharmacology 27 2007 171 176 (Pubitemid 46594934)